Market Tracker

07/22 5:16pm ET

TG Therapeutics Inc (NASDAQ:TGTX)

5.83
Delayed Data
As of Jul 22
 -0.21 / -3.48%
Today’s Change
5.61
Today|||52-Week Range
18.60
-51.13%
Year-to-Date

Today’s Trading

Previous close6.04
Today’s open6.04
Day’s range5.77 - 6.07
Volume250,336
Average volume (3 months)408,418
Market cap$328.2M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+15.85%
Earnings growth (this year)+16.67%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales3,573.69
Price/Book3.21

Competitors

 Today’s
change
Today’s
% change
AKBAAkebia Therapeutics ...+0.02+0.23%
VSARVersartis Inc-0.04-0.36%
SVASinovac Biotech Ltd+0.01+0.17%
NLNKNewLink Genetics Cor...+0.14+1.29%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$152.4K
Annual profit (last year)-$62.9M
Net profit margin-41,310.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael Sean Weiss
CFO, Secretary, Treasurer &
CAO
Sean A. Power
Corporate headquarters
New York, New York

Forecasts